A cadmium(ii)-based MOF, Cd-MDIP, was successfully prepared by hydrothermal reaction between the tetra-carboxylic ligand 5,5'-methylenebisophthalic acid (H4MDIP) and cadmium perchlorate. The X-ray crystal structure analysis showed that there are two uncoordinated carboxyl groups in each ligand and a 1D elliptical channel along the [001] direction. Because of the existence of uncoordinated carboxyl groups within open frameworks, Cd-MDIP exhibited a high sensitivity (Stern-Volmer constant KSV = 4.13 × 104 L mol-1) and a low detection limit (80 nM) for Fe3+ ions in pure water, which is much lower than the national standard for Fe3+ in daily drinking water (5.4 μM) set by the Ministry of Environmental Protection of P. R. China. Most importantly, Cd-MDIP also featured the ultrahigh adsorption of Fe3+ in aqueous solution that cannot be destroyed even by EDTA/base. Importantly, the MOF material (Cd-MDIP⊃Fe3+) after adsorbing Fe3+ could act as the first example of an excellent bi-metallic Lewis-acid catalyst for the cyanosilylation reaction of aromatic aldehydes in a size-selective fashion, and its efficiency was almost 10-times higher than that of the original Cd-MDIP.
Herein, we developed the dual-function template method to fabricate hollow magnetic nano-spheres (denoted as HMNPs-Cn, n = 16, 18) with a mesoporous shell and hollow interior structure using alkyl chain trimethoxysilane templating. The microstructure of the HMNPs-Cn was investigated by means of XRD, FT-IR, EDS, SEM, TEM and N2-BET analyses. The shorter chain template directed formation of HMNPs-C16 with size of 119 nm, having disordered inkbottle type mesopores and saturation magnetization of 50.01 emu/g. It can be observed that, mitomycin C (MMC) loaded HMNPs-Cn hollow spheres showed a clear pH-dependent drug release behavior, having a higher release rate in acidic environments of pH 5.7. For the pH 5.7 and 7.4 release, the diffusion through HMNPs-Cn hollow spheres is the rate limiting step, the release kinetic for HMNPs-C16-MMC composites follows pseudo-first-order attributable to its special pore structure. For this reason the inner cavity of HMNPs-C16 could be labeled with radioisotope 99Tcm to study the magnetic targeting distribution of HMNPs-C16 in vivo, and its cytotoxicity against in vitro HeLa cells was also studied. These results indicate the potential of HMNPs-C16 in the magnetic targeted drug delivery system.
Herein, we developed the dual-function template method to fabricate hollow magnetic nano-spheres (denoted as HMFe-Si-Cn, n=16, 18) with a mesoporous shell and hollow interior structure using alkyl chain trimethoxysilane templating. The shorter chain template directed formation of HMFe-Si-C16 with size of 119 nm, having disordered inkbottle type mesopores and saturation magnetization of 50.01 emu/g higher than that of HMFe-Si-C18 with cylindrical type mesopores. By contrast, Mitomycin C (MMC) loading efficiency of HMFe-Si-C16 was higher owing to the fact that the pore size, surface area, and pore volume of HMFe-Si-C16 were larger than those of HMFe-Si-C18. Besides, MMC loaded HMFe-Si-Cn hollow spheres showed a clear pH-dependent drug release behavior, having a higher release rate in acidic environments of pH 5.7. For the pH 5.7 and 7.4 release, the release kinetic for HMFe-Si-C16-MMC composites follows pseudo-first-order attributable to its special pore structure. For this reason the inner cavity of HMFe-Si-C16 could be labeled with radioisotope 99Tcm to study the magnetic targeting distribution of HMFe-Si-C16 in vivo, and its cytotoxicity against in vitro HeLa cells was also studied. These results indicate the potential of HMFe-Si-C16 in the magnetic targeted drug delivery system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.